Govt Job: For M.Pharm, MS Pharm, M.Sc for a project sponsored NIPER

The National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, is an Institute of National Importance with the proclaimed objective of becoming a Centre of Excellence for advanced research in pharmaceutical sciences.

The NIPER-Mohali was the first institute established in the year 1998 under the aegis of the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, the Govt. of India.

Later, the DOP established 6 new NIPERs across the country including NIPER-Hyderabad which started functioning on 19th October 2007, from the premises of the erstwhile R&D Centre of IDPL, Balanagar, Hyderabad.

Post: Junior Research Fellow (JRF)

Applications are invited for the post of Junior Research Fellow (JRF) to work on the following project sponsored by Science and Engineering Research Board, Department of Science and Technology, Government of India (SERB-SRG) under the supervision of Dr. Amol G. Dikundwar in Solid State Characterization group at Department of Pharmaceutical Analysis, NIPER Hyderabad.

The title of the project is Co-amorphous Forms for Bioavailability Enhancement of Poorly Soluble Drugs: Design, Synthesis, Characterization, and in vivo Studies.

Essential Qualifications: M.Pharm./M.S.Pharm with Pharmaceutics/Pharmaceutical Technology/Pharmaceutical Analysis specialization or M.Sc. Chemistry/Physics with Materials Science specialization/curriculum. Candidates with sound knowledge and demonstrated experience (e.g., Masters’s project thesis) in the field of solid-state pharmaceutics are preferred.

Age not exceeding 35 years as of the last date of application.

Salary: 31,000/- per month (plus HRA as per DST norms)

How to Apply: A detailed resume including the applicant’s personal details with photographs, educational background, statement of purpose, professional reference for a recommendation, and a copy of all credentials should be submitted by email (amol.dikundwar@niperhyd.ac.in). An incomplete application will not be considered.

Last Date of Application: 29th October 2022

Date of Interview: Interviews will be held as soon as possible thereafter.

Note: Only shortlisted candidates will be intimated to appear for an interview (online or offline); no TA/DA will be paid for attending the same.

Dr. Amol G. Dikundwar
Department of Pharmaceutical Analysis,
NIPER-Hyderabad, 500037.
Email: amol.dikundwar@niperhyd.ac.in

Related Posts

Diabetic drug metformin found to act on brain

NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

Hetero debuts semaglutide generic in emerging markets

New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Diabetic drug metformin found to act on brain

Diabetic drug metformin found to act on brain

Hetero debuts semaglutide generic in emerging markets

Hetero debuts semaglutide generic in emerging markets

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework